NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+19.0%
5Y CAGR+17.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+19.0%/yr
vs +6.6%/yr prior
5Y CAGR
+17.3%/yr
Consistent
Acceleration
+12.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$45.63B+2.9%
2025$44.32B+10.7%
2024$40.02B+47.8%
2023$27.09B+39.2%
2022$19.46B-5.3%
2021$20.56B+7.4%
2020$19.15B-8.6%
2019$20.95B-4.1%
2018$21.85B+8.1%
2017$20.20B-